Healthcare technology companies Function Health and Ezra have announced their merger, with Function Health acquiring Ezra to integrate full-body MRI imaging with lab-based health assessments. The move brings together two emerging players in preventive health, combining Ezra’s AI-powered imaging technology with Function Health’s biomarker testing platform. As a result of the acquisition, the companies are launching a $500 full-body MRI scan, currently available to Function Health’s members.
Ezra, founded in 2018 by Romanian entrepreneur Emi Gal, developed AI tools to reduce the time and cost of full-body MRI scans. The company offers scans that screen for cancer and over 500 other conditions across up to 13 organs. Its FDA-cleared Ezra Flash AI technology allows for faster imaging while maintaining quality, enabling full scans to be completed in approximately 22 minutes, compared to the typical one-hour duration.
Before the acquisition, Ezra offered a full-body scan in the US for $2,500, a significant reduction from conventional prices that could reach up to $20,000. The new $500 scan will be offered at nearly 100 imaging partner locations initially, with plans to expand to more than 1,000 sites in the coming months.
“I started Ezra with a clear mission: to detect cancer early for everyone in the world,” says Emi Gal, founder of Ezra. “This mission is deeply personal for me—if my mother had detected cancer early, she would still be alive today. Over the past six years my team and I have helped countless people find cancer, many of whom are now cancer free. We are now scaling this to millions together with Function.”
Last year, Ezra announced their €18.5M round led by Healthier Capital, the VC firm started by Amir Dan Rubin, the former CEO of Amazon’s One Medical. FirstMark Capital co-led the round, with participation from Allianz Life Ventures (venture arm of Allianz Life Insurance Company of North America), the Schwarzman family, and the former Chairman of England’s NHS Lord David Prior. Existing investors Credo Ventures, Seedcamp, LDV Capital, Accomplice, Founders Future, Vlad Tenev, Anne Wojcicki, and Esther Dyson also participated.
Function Health, launched in 2023, offers a membership model for lab testing, providing access to over 160 biomarkers—including heart, hormone, thyroid, immunity, and cancer indicators—for $499 per year. The company reports that it has 100,000 paying members and a waitlist of approximately 500,000 individuals. It operates through partnerships with 2,200 Quest Diagnostics locations across the United States.
“Adding imaging was part of our vision from day one,” says Jonathan Swerdlin, co-founder and CEO of Function Health. “Our brilliant team first focused on making comprehensive lab testing affordable and widely available. Now with Ezra becoming a part of Function, we complete the picture. It’s time everyone owns their health, every year. This is the best use of AI—applying it directly to human life.”
In 2024, Function Health raised €46.7M in Series A funding led by Andreessen Horowitz, with participation from a number of individual investors.
